| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |